# Correction: RPL28 mediates sorafenib resistance in hepatocellular carcinoma by downregulating CDC6 expression

**Authors:** Yi Shi, Fangfang Chen, Yuanyuan Weng, Hang Zeng, Gang Chen

PMC · DOI: 10.3389/fonc.2026.1814738 · Frontiers in Oncology · 2026-03-04

## Full-text entities

- **Genes:** RPL28 (ribosomal protein L28) [NCBI Gene 6158] {aka L28, eL28}, CDC6 (cell division cycle 6) [NCBI Gene 990] {aka CDC18L, HsCDC18, HsCDC6, MGORS5}
- **Diseases:** hepatocellular carcinoma (MESH:D006528)
- **Chemicals:** sorafenib (MESH:D000077157)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12996831/full.md

---
Source: https://tomesphere.com/paper/PMC12996831